Web Analytics

3 Latest Announced Rounds

  • $38,000,000
    Series C

    1 Investors

    Financial Services
    Aug 5th, 2025
  • $8,000,000
    Unknown
    Pharmaceutical Manufacturing
    Aug 5th, 2025
  • $2,600,000
    Pre-Seed

    2 Investors

    Software Development
    Aug 5th, 2025
$1,022.75M Raised in 43 Funding Rounds in the past 7 Days - View All

Funding Round Profile

IMU Biosciences

start up
United Kingdom - London
  • 25/01/2024
  • Series A
  • $14,639,787

Mapping the immune system in unprecedented detail and scale. IMU’s discovery platform is building a new understanding of the immune system across health and disease, through next generation high resolution, systems-level immune profiling with AI & ML analytics.


Related People

Adam LaingCo Founder

Adam Laing United Kingdom - London, England

N/A